CVS Pharmacy Suspends Sale of Zantac Products -- and More -- Due to FDA Investigation

CVS Pharmacy Suspends Sale of Zantac Products -- and More -- Due to FDA Investigation

CVS Pharmacy has suspended the sale of all Zantac brand and CVS Health ranitidine products until further notice.

“This action is being taken out of an abundance of caution due to a recent Product Alert from the U.S. Food and Drug Administration (FDA) that ranitidine products may contain a low level of nitrosodimethylamine (NDMA), which is a probable human carcinogen,” writes CVS in their press release.

CVS adds that the products have not been recalled, and the FDA is not recommending that patients stop taking ranitidine.

GET THE LATEST BREAKING NEWS HERE -- SIGN UP FOR GOLOCAL FREE DAILY EBLAST

However, customers who purchased the products can return them to CVS for a refund.

CVS will continue to sell other over-the-counter H2 Blockers, including Pepcid, Tagamet and its respective generic equivalents, famotidine and cimetidine.

FDA Investigation

Ranitidine is an H2 Blocker that is taken to provide heartburn relief.

The suspension of the products comes as the FDA is continuing to evaluate whether low levels of NDMA in ranitidine pose a risk to patients.

According to CVS, the levels that FDA is finding in ranitidine from preliminary tests barely exceed amounts found in common foods.